GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Dividend Yield %

Intravenous Infusions (XGHA:IIL) Dividend Yield % : 0.00% (As of Jun. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Dividend Yield %?

As of today (2024-06-15), the Trailing Annual Dividend Yield of Intravenous Infusions is 0.00%.

The historical rank and industry rank for Intravenous Infusions's Dividend Yield % or its related term are showing as below:

During the past 0 years, the highest Dividend Yield of Intravenous Infusions was 12.80%. The lowest was 0.00%. And the median was 0.00%.

XGHA:IIL's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.83
* Ranked among companies with meaningful Dividend Yield % only.

Intravenous Infusions's Dividend Payout Ratio for the six months ended in . 20 was 0.00.

As of today (2024-06-15), the Forward Dividend Yield % of Intravenous Infusions is 0.00%.

Intravenous Infusions's Dividends per Share for the six months ended in . 20 was GHS0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Intravenous Infusions Dividend Yield % Historical Data

The historical data trend for Intravenous Infusions's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Dividend Yield % Chart

Intravenous Infusions Annual Data
Trend
Dividend Yield %

Intravenous Infusions Semi-Annual Data
Dividend Yield %

Competitive Comparison of Intravenous Infusions's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intravenous Infusions's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Dividend Yield % falls into.



Intravenous Infusions Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Intravenous Infusions  (XGHA:IIL) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Intravenous Infusions Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.